<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>龙谈价值 | wechat-feeds</title><link>http://MzAxNjI0NTM2NQ.favicon.privacyhide.com/favicon.ico</link><description>中型私募医药研究负责人、医药股投资经理，深挖行业及公司基本面，守正出奇，坚守价值</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 20 Apr 2021 23:23:31 +0800</pubDate><image><url>http://MzAxNjI0NTM2NQ.favicon.privacyhide.com/favicon.ico</url><title>龙谈价值 | wechat-feeds</title><link>http://MzAxNjI0NTM2NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>创新药总龙头的低吼</title><link>https://mp.weixin.qq.com/s/CUqR48mZVIfkduqvVZewEA</link><description></description><content:encoded><![CDATA[创新药总龙头的低吼]]></content:encoded><pubDate>Tue, 20 Apr 2021 23:08:10 +0800</pubDate></item><item><title>国产创新药崛起之路</title><link>https://mp.weixin.qq.com/s/Zr5Nxg7KrWQ1UK81t-jjFQ</link><description></description><content:encoded><![CDATA[国产创新药崛起之路]]></content:encoded><pubDate>Thu, 15 Apr 2021 20:41:54 +0800</pubDate></item><item><title>潜在超级成长股的年报如何？</title><link>https://mp.weixin.qq.com/s/yGfO-ExuoY6xLnLQLbsmYA</link><description></description><content:encoded><![CDATA[潜在超级成长股的年报如何？]]></content:encoded><pubDate>Tue, 13 Apr 2021 20:19:57 +0800</pubDate></item><item><title>持续高速成长的器械细分龙头</title><link>https://mp.weixin.qq.com/s/0K4TYe12_rSA8f04KOVzBw</link><description></description><content:encoded><![CDATA[持续高速成长的器械细分龙头]]></content:encoded><pubDate>Thu, 08 Apr 2021 20:31:27 +0800</pubDate></item><item><title>上市以来一直在超预期的优秀公司</title><link>https://mp.weixin.qq.com/s/iZWMJXFvi7WuDGjpBH8oeg</link><description></description><content:encoded><![CDATA[上市以来一直在超预期的优秀公司]]></content:encoded><pubDate>Tue, 06 Apr 2021 21:11:00 +0800</pubDate></item><item><title>另一家顶尖成长股之——打虎亲兄弟</title><link>https://mp.weixin.qq.com/s/xDRfiOgF5E-Va00lZyqelA</link><description></description><content:encoded><![CDATA[另一家顶尖成长股之——打虎亲兄弟]]></content:encoded><pubDate>Thu, 01 Apr 2021 20:39:36 +0800</pubDate></item><item><title>高瓴早已洞穿趋势！CXO最重磅的未来，不在于大分子CDMO！</title><link>https://mp.weixin.qq.com/s/9U_abSqx_ZDNdAtf1ecodg</link><description></description><content:encoded><![CDATA[高瓴早已洞穿趋势！CXO最重磅的未来，不在于大分子CDMO！]]></content:encoded><pubDate>Thu, 01 Apr 2021 20:39:36 +0800</pubDate></item><item><title>顶尖超级成长股</title><link>https://mp.weixin.qq.com/s/_cDbDPbmUNz7PwritDFBsg</link><description></description><content:encoded><![CDATA[顶尖超级成长股]]></content:encoded><pubDate>Tue, 30 Mar 2021 20:46:25 +0800</pubDate></item><item><title>创新疗法的未来，中国企业已至</title><link>https://mp.weixin.qq.com/s/bv10q-3x1ef8c7ZbWX-t5A</link><description></description><content:encoded><![CDATA[创新疗法的未来，中国企业已至]]></content:encoded><pubDate>Thu, 25 Mar 2021 20:30:51 +0800</pubDate></item><item><title>海外创新药巨头梳理</title><link>https://mp.weixin.qq.com/s/Ex9yd-wiljFvCmVsBJmSeA</link><description></description><content:encoded><![CDATA[海外创新药巨头梳理]]></content:encoded><pubDate>Tue, 23 Mar 2021 20:35:54 +0800</pubDate></item><item><title>国内创新药核心公司梳理（上篇）</title><link>https://mp.weixin.qq.com/s/_fNOL5qvGm6K3qrk5jcXhA</link><description></description><content:encoded><![CDATA[国内创新药核心公司梳理（上篇）]]></content:encoded><pubDate>Tue, 23 Mar 2021 20:35:54 +0800</pubDate></item><item><title>国内创新药核心公司梳理（下篇）</title><link>https://mp.weixin.qq.com/s/P7UHgrvFNSvZldL5qBiQlg</link><description></description><content:encoded><![CDATA[国内创新药核心公司梳理（下篇）]]></content:encoded><pubDate>Tue, 23 Mar 2021 20:35:54 +0800</pubDate></item><item><title>谈一家特色领域小龙头</title><link>https://mp.weixin.qq.com/s/mlRT78p4B0IdMSTC_2wZIw</link><description></description><content:encoded><![CDATA[谈一家特色领域小龙头]]></content:encoded><pubDate>Thu, 18 Mar 2021 20:13:25 +0800</pubDate></item></channel></rss>